Dow skids over 200 points lower at Tuesday's open as Moderna CEO raises doubt about current batch of vaccines versus omicron

U.S. stock benchmarks headed lower Tuesday morning, giving up some of Monday's gains, amid fresh concerns that the new omicron strain of coronavirus is more resistant to the current batch of vaccines. Moderna /zigman2/quotes/205619834/composite MRNA -1.68% Chief Executive Stéphane Bancel told the Financial Times in an interview. The Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.60% was down 0.8%, the S&P 500 index /zigman2/quotes/210599714/realtime SPX +0.16% declined 0.6% at 4,627, while the Nasdaq Composite Index /zigman2/quotes/210598365/realtime COMP -0.47% retreated 0.4% at 15,717. The 10-year benchmark Treasury note was yielding 1.44%, down from 1.529% on Monday at 3 p.m. Eastern Time.

/zigman2/quotes/205619834/composite

Add to watchlist MRNA

Moderna Inc.

US : U.S.: Nasdaq

$ 148.35

-2.53 -1.68%

Volume: 2.64M

March 27, 2023 4:00p

P/E Ratio

7.43

Dividend Yield

N/A

Market Cap

$58.29 billion

Rev. per Employee

$4.90M

/zigman2/quotes/210598065/realtime

Add to watchlist DJIA

Dow Jones Industrial Average

US : Dow Jones Global

32,432.08

+194.55 +0.60%

Volume: 0.00

March 27, 2023 5:00p

/zigman2/quotes/210599714/realtime

Add to watchlist SPX

S&P 500 Index

US : S&P US

3,977.53

+6.54 +0.16%

Volume: 0.00

March 27, 2023 5:00p

/zigman2/quotes/210598365/realtime

Add to watchlist COMP

NASDAQ Composite Index

US : Nasdaq

11,768.84

-55.12 -0.47%

Volume: 4.35B

March 27, 2023 5:16p